Guidance for industry : minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies.

Bibliographic Details
Corporate Author:	Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
Subjects:	Fetal blood. Hematopoiesis. Hematoma. Blood banks > Licenses > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS112475

Description
Item Description:	Title from PDF title page (viewed on May 11, 2009). "Draft guidance." "December 2006". Electronic resource.
Physical Description:	ii, 46 pages : digital, PDF file.
Format:	Mode of access: Internet at the FDA CBER web site. Address as of 5/11/09: http://www.fda.gov/cber/gdlns/cordbld.pdf ; current access is available via PURL.
Bibliography:	Includes bibliographical references (page 46).